Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q1 2026 ▲▼ | Q2 2026 ▲▼ | Change ▲▼ | Q1 2026 ▲▼ | Q2 2026 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Erasca, Inc.(ERAS) | 11,150,000 | 12,150,000 | +1,000,000 | $180.41M | $222.59M | 9.58% | +$42.18M |
| ABIVAX Société AnonymeADS(ABVX) | 675,000 | 1,024,000 | +349,000 | $75.16M | $136.46M | 5.87% | +$61.30M |
| Revolution Medicines, Inc.(RVMD) | 2,000,000 | 700,000 | -1,300,000 | $194.50M | $131.10M | 5.64% | -$63.40M |
| IDEAYA Biosciences, Inc.(IDYA) | 3,450,000 | 3,000,000 | -450,000 | $114.95M | $111.81M | 4.81% | -$3.14M |
| BioNTech SEADS(BNTX) | 0 | 1,015,000 | +1,015,000 | $0 | $94.45M | 4.07% | +$94.45M |
| Vera Therapeutics, Inc.CL A(VERA) | 0 | 2,200,000 | +2,200,000 | $0 | $94.40M | 4.06% | +$94.40M |
| Tango Therapeutics, Inc.(TNGX) | 3,000,000 | 2,850,000 | -150,000 | $62.76M | $89.09M | 3.84% | +$26.33M |
| Praxis Precision Medicines, Inc.(PRAX) | 285,000 | 260,000 | -25,000 | $91.82M | $87.05M | 3.75% | -$4.78M |
| Celldex Therapeutics, Inc.(CLDX) | 450,000 | 2,100,000 | +1,650,000 | $14.27M | $78.14M | 3.36% | +$63.87M |
| Dianthus Therapeutics, Inc.(DNTH) | 400,000 | 800,000 | +400,000 | $33.57M | $77.98M | 3.36% | +$44.42M |
| CG Oncology, Inc.(CGON) | 575,000 | 1,000,000 | +425,000 | $38.92M | $71.05M | 3.06% | +$32.13M |
| Disc Medicine, Inc.(IRON) | 560,000 | 875,000 | +315,000 | $35.81M | $64.00M | 2.76% | +$28.19M |
| Maze Therapeutics, Inc.(MAZE) | 1,235,000 | 1,935,000 | +700,000 | $36.86M | $57.74M | 2.49% | +$20.88M |
| Dyne Therapeutics, Inc.(DYN) | 1,400,000 | 2,550,000 | +1,150,000 | $25.38M | $56.64M | 2.44% | +$31.25M |
| MoonLake ImmunotherapeuticsCL A(MLTX) | 1,500,000 | 2,675,000 | +1,175,000 | $27.96M | $52.08M | 2.24% | +$24.12M |
| Ocular Therapeutix, Inc.(OCUL) | 3,850,000 | 5,300,000 | +1,450,000 | $32.61M | $52.05M | 2.24% | +$19.44M |
| Design Therapeutics, Inc.(DSGN) | 1,950,000 | 3,000,000 | +1,050,000 | $20.75M | $43.41M | 1.87% | +$22.66M |
| Olema Pharmaceuticals, Inc.(OLMA) | 3,208,875 | 3,208,875 | 0 | $47.84M | $40.14M | 1.73% | -$7.70M |
| Belite Bio, IncADS(BLTE) | 0 | 250,000 | +250,000 | $0 | $38.50M | 1.66% | +$38.50M |
| Achieve Life Science Inc | 0 | 5,425,000 | +5,425,000 | $0 | $35.43M | 1.53% | +$35.43M |
| Trevi Therapeutics, Inc.(TRVI) | 2,400,000 | 1,880,000 | -520,000 | $28.63M | $35.06M | 1.51% | +$6.43M |
| Cogent Biosciences, Inc.(COGT) | 0 | 900,000 | +900,000 | $0 | $34.83M | 1.50% | +$34.83M |
| ArriVent BioPharma, Inc.(AVBP) | 350,000 | 1,000,000 | +650,000 | $8.07M | $34.74M | 1.50% | +$26.67M |
| Crescent Biopharma, Inc.(CBIO) | 482,500 | 1,900,000 | +1,417,500 | $8.86M | $34.20M | 1.47% | +$25.34M |
| COMPASS Pathways plcADS(CMPS) | 0 | 2,250,000 | +2,250,000 | $0 | $31.84M | 1.37% | +$31.84M |
| Mineralys Therapeutics, Inc.(MLYS) | 0 | 1,050,000 | +1,050,000 | $0 | $28.33M | 1.22% | +$28.33M |
| Replimune Group, Inc.(REPL) | 0 | 2,500,000 | +2,500,000 | $0 | $27.68M | 1.19% | +$27.68M |
| Xenon Pharmaceuticals Inc.(XENE) | 450,000 | 450,000 | 0 | $26.17M | $27.16M | 1.17% | +$994.5K |
| Structure Therapeutics IncADS | 500,000 | 500,000 | 0 | $24.10M | $26.84M | 1.16% | +$2.73M |
| Immunovant, Inc.(IMVT) | 1,075,000 | 665,000 | -410,000 | $26.70M | $25.62M | 1.10% | -$1.08M |
| Jade Biosciences Inc | 400,000 | 1,125,000 | +725,000 | $5.62M | $25.00M | 1.08% | +$19.38M |
| Enliven Therapeutics Inc | 540,000 | 465,000 | -75,000 | $21.17M | $23.60M | 1.02% | +$2.43M |
| Veradermics, Incorporated(MANE) | 25,000 | 180,000 | +155,000 | $1.58M | $22.13M | 0.95% | +$20.55M |
| Avalo Therapeutics, Inc.(AVTX) | 300,000 | 1,150,000 | +850,000 | $4.48M | $21.25M | 0.91% | +$16.77M |
| Arcus Biosciences, Inc.(RCUS) | 1,200,000 | 650,000 | -550,000 | $25.92M | $20.04M | 0.86% | -$5.88M |
| Summit Therapeutics Inc.(SMMT) | 0 | 1,350,000 | +1,350,000 | $0 | $19.67M | 0.85% | +$19.67M |
| Immunocore Holdings plcADS(IMCR) | 1,500,000 | 600,000 | -900,000 | $45.23M | $19.05M | 0.82% | -$26.18M |
| LB Pharmaceuticals Inc(LBRX) | 915,000 | 585,000 | -330,000 | $22.56M | $18.99M | 0.82% | -$3.58M |
| Minerva Neurosciences, Inc.(NERV) | 3,215,000 | 3,288,777 | +73,777 | $19.37M | $18.25M | 0.79% | -$1.12M |
| Faeth Therapeutics, Inc.(FTH) | 30,000 | 722,020 | +692,020 | $945.6K | $18.05M | 0.78% | +$17.10M |
| CRISPR Therapeutics AGNAMEN AKT(CRSP) | 0 | 300,000 | +300,000 | $0 | $16.36M | 0.70% | +$16.36M |
| DBV Technologies S.A.ADS(DBVT) | 0 | 915,000 | +915,000 | $0 | $15.01M | 0.65% | +$15.01M |
| Parabilis Medicines Inc | 0 | 525,000 | +525,000 | $0 | $14.37M | 0.62% | +$14.37M |
| Rhythm Pharmaceuticals, Inc.(RYTM) | 450,000 | 125,000 | -325,000 | $39.14M | $13.88M | 0.60% | -$25.26M |
| Vor Biopharma Inc.(VOR) | 750,000 | 650,000 | -100,000 | $13.38M | $11.97M | 0.52% | -$1.41M |
| Scholar Rock Holding Corporation(SRRK) | 0 | 200,000 | +200,000 | $0 | $11.00M | 0.47% | +$11.00M |
| Immix Biopharma, Inc.(IMMX) | 1,225,000 | 1,000,000 | -225,000 | $11.16M | $10.31M | 0.44% | -$849.8K |
| Q32 Bio Inc.(QTTB) | 0 | 800,000 | +800,000 | $0 | $10.19M | 0.44% | +$10.19M |
| Odyssey Therapeutics Inc | 0 | 521,736 | +521,736 | $0 | $9.76M | 0.42% | +$9.76M |
| Annexon, Inc.(ANNX) | 0 | 1,500,000 | +1,500,000 | $0 | $8.56M | 0.37% | +$8.56M |
| Editas Medicine, Inc.(EDIT) | 0 | 2,222,000 | +2,222,000 | $0 | $7.20M | 0.31% | +$7.20M |
| Relay Therapeutics, Inc.(RLAY) | 750,000 | 350,000 | -400,000 | $7.46M | $6.55M | 0.28% | -$914.0K |
| Acadia Pharmaceuticals Inc | 750,000 | 250,000 | -500,000 | $16.70M | $6.33M | 0.27% | -$10.37M |
| Amylyx Pharmaceuticals, Inc.(AMLX) | 700,000 | 350,000 | -350,000 | $9.73M | $6.29M | 0.27% | -$3.44M |
| Cybin D/B/A Helus Pharma(HELP) | 0 | 750,000 | +750,000 | $0 | $4.96M | 0.21% | +$4.96M |
| OnKure Therapeutics, Inc.CL A(OKUR) | 0 | 963,855 | +963,855 | $0 | $4.40M | 0.19% | +$4.40M |
| Tenax Therapeutics, Inc.(TENX) | 625,000 | 300,000 | -325,000 | $9.99M | $4.37M | 0.19% | -$5.63M |
| Definium Therapeutics, Inc.(DFTX) | 0 | 80,000 | +80,000 | $0 | $3.76M | 0.16% | +$3.76M |
| Unicycive Therapeutics, Inc.(UNCY) | 473,563 | 473,563 | 0 | $3.12M | $2.22M | 0.10% | -$895.0K |
| Palatin Technologies, Inc.(PTN) | 140,000 | 130,000 | -10,000 | $2.44M | $1.40M | 0.06% | -$1.04M |
| uniQure N.V.SHS(QURE) | 0 | 30,000 | +30,000 | $0 | $1.38M | 0.06% | +$1.38M |
| Jatt Ii Acquisition Corp | 0 | 100,000 | +100,000 | $0 | $1.14M | 0.05% | +$1.14M |
| Research Alliance Corp IiiCL A | 0 | 100,000 | +100,000 | $0 | $1.07M | 0.05% | +$1.07M |
| Aclaris Therapeutics, Inc.(ACRS) | 500,000 | 200,000 | -300,000 | $1.88M | $1.06M | 0.05% | -$817.0K |
| Longeveron Inc.CL A(LGVN) | 0 | 1,287,000 | +1,287,000 | $0 | $904.8K | 0.04% | +$904.8K |
| Fractyl Health, Inc.(GUTS) | 1,000,000 | 1,000,000 | 0 | $457.8K | $794.4K | 0.03% | +$336.6K |
| Septerna, Inc.(SEPN) | 23,548 | 23,548 | 0 | $565.9K | $788.6K | 0.03% | +$222.8K |
| Amanat Acquisition CorpCL A | 0 | 50,000 | +50,000 | $0 | $508.0K | 0.02% | +$508.0K |
| Alkermes plcSHS(ALKS) | 350,000 | 0 | -350,000 | $12.38M | $0 | — | -$12.38M |
| Biogen Inc.(BIIB) | 200,000 | 0 | -200,000 | $36.67M | $0 | — | -$36.67M |
| Centessa Pharmaceuticals PlcADS | 2,125,000 | 0 | -2,125,000 | $84.41M | $0 | — | -$84.41M |
| Compass Therapeutics, Inc.(CMPX) | 3,150,000 | 0 | -3,150,000 | $16.66M | $0 | — | -$16.66M |
| Corvus Pharmaceuticals, Inc.(CRVS) | 450,000 | 0 | -450,000 | $6.58M | $0 | — | -$6.58M |
| Cytokinetics, Incorporated(CYTK) | 875,000 | 0 | -875,000 | $57.67M | $0 | — | -$57.67M |
| iBio, Inc.(IBIO) | 1,300,000 | 0 | -1,300,000 | $2.47M | $0 | — | -$2.47M |
| Janux Therapeutics, Inc.(JANX) | 1,000,000 | 0 | -1,000,000 | $13.90M | $0 | — | -$13.90M |
| Madrigal Pharmaceuticals, Inc.(MDGL) | 85,000 | 0 | -85,000 | $44.49M | $0 | — | -$44.49M |
| MeiraGTx Holdings plc(MGTX) | 700,000 | 0 | -700,000 | $6.06M | $0 | — | -$6.06M |
| Mirum Pharmaceuticals, Inc.(MIRM) | 200,000 | 0 | -200,000 | $18.48M | $0 | — | -$18.48M |
| Newamsterdam Pharma Company ORDINARY SHARES | 600,000 | 0 | -600,000 | $19.21M | $0 | — | -$19.21M |
| ORIC Pharmaceuticals, Inc.(ORIC) | 950,000 | 0 | -950,000 | $12.04M | $0 | — | -$12.04M |
| Pharvaris N V COM | 65,000 | 0 | -65,000 | $1.84M | $0 | — | -$1.84M |
| Soleno Therapeutics Inc | 250,000 | 0 | -250,000 | $8.37M | $0 | — | -$8.37M |
| Terns Pharmaceuticals Inc | 1,500,000 | 0 | -1,500,000 | $79.08M | $0 | — | -$79.08M |
| Tyra Biosciences, Inc.(TYRA) | 850,000 | 0 | -850,000 | $32.55M | $0 | — | -$32.55M |
| United Therapeutics Corporation(UTHR) | 80,000 | 0 | -80,000 | $47.44M | $0 | — | -$47.44M |
| Vaxcyte, Inc.(PCVX) | 300,000 | 0 | -300,000 | $17.43M | $0 | — | -$17.43M |
| Verastem, Inc.(VSTM) | 1,000,000 | 0 | -1,000,000 | $5.30M | $0 | — | -$5.30M |